Decentralized solutions have been prioritized across the industry to address immediate needs for both COVID-19 studies and unrelated trials disturbed by the effects of the pandemic, but these solutions hold longer term potential. They offer future standards for study development, allowing greater patient access and interactions that will enhance future research, all while maintaining patient safety. Learn more.